Advanced in Folliculitis

Dr. Eric Simpson

Dermatology
Oregon Health & Science University
3303 S Bond Ave, 
Portland, OR 
Offers Telehealth

Advanced in Folliculitis
Oregon Health & Science University
3303 S Bond Ave, 
Portland, OR 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Eric Simpson is a Dermatologist in Portland, Oregon. Dr. Simpson is rated as an Advanced provider by MediFind in the treatment of Folliculitis. His top areas of expertise are Atopic Dermatitis, Psoriasis, Plaque Psoriasis, and Actinic Keratosis.

His clinical research consists of co-authoring 434 peer reviewed articles and participating in 13 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Folliculitis.

Specialties
Dermatology
Licenses
Dermatology in OR
Hospital Affiliations
Ohsu Hospital And Clinics
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
ATRIO Health
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE PART D
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
BridgeSpan
  • EPO
  • HMO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health
  • EPO
  • HMO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

HMSA
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser
  • EPO
  • HMO
  • POS
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Moda Health
  • EPO
  • PPO
PacificSource
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Regence
  • EPO
  • PPO
Samaritan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Trillium
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 21 Less Insurance Carriers -

Locations

Oregon Health & Science University
3303 S Bond Ave, Portland, OR 97239
Call: 503-418-3376
Other Locations
OHSU Hospital
3181 SW Sam Jackson Park Rd, Portland, OR 97239
Call: 503-418-3376

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


12 Clinical Trials

A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
Enrollment Status: Completed
Publish Date: November 05, 2025
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
Multicenter Diagnostic Imaging Study for the Melanoma Advanced Imaging Dermatoscope (mAID)
Multicenter Diagnostic Imaging Study for the Melanoma Advanced Imaging Dermatoscope (mAID)
Enrollment Status: Completed
Publish Date: May 24, 2023
An Open-Label, Single-Arm Study to Assess the Safety and Efficacy of Lebrikizumab in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis
An Open-Label, Single-Arm Study to Assess the Safety and Efficacy of Lebrikizumab in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: February 24, 2023
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Multicenter, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
A Multicenter, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Terminated
Publish Date: November 08, 2022
Intervention Type: Drug
Study Drug: Baricitnib
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: September 09, 2022
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled Trial To Evaluate The Efficacy and Safety of Lebrikizumab When Used In Combination With Topical Corticosteroid Treatment In Patients With Moderate-To-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled Trial To Evaluate The Efficacy and Safety of Lebrikizumab When Used In Combination With Topical Corticosteroid Treatment In Patients With Moderate-To-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: May 09, 2022
Intervention Type: Other, Biological
Study Drugs: Lebrikizumab, Topical Corticosteroid
Study Phase: Phase 3
Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis, Dupilumab Study
Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis, Dupilumab Study
Enrollment Status: Terminated
Publish Date: October 04, 2021
Intervention Type: Drug
Study Phase: Phase 4
A Randomized Pilot Trial Comparing Cetaphil® Restoraderm® System and Standard Skin Care in Infants at Risk for Atopic Dermatitis
A Randomized Pilot Trial Comparing Cetaphil® Restoraderm® System and Standard Skin Care in Infants at Risk for Atopic Dermatitis
Enrollment Status: Completed
Publish Date: February 12, 2020
Intervention Type: Other
Study Phase: Not Applicable
Group Eczema Education Visits:Impact on Patient and Family Quality of Life
Group Eczema Education Visits:Impact on Patient and Family Quality of Life
Enrollment Status: Completed
Publish Date: July 11, 2019
Intervention Type: Other
Study Phase: Not Applicable
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Enrollment Status: Completed
Publish Date: December 13, 2017
Intervention Type: Drug
Study Phase: Phase 2
Effects of a Novel Formulation of Fluocinonide 0.1% Cream on Skin Barrier Function in Atopic Dermatitis
Effects of a Novel Formulation of Fluocinonide 0.1% Cream on Skin Barrier Function in Atopic Dermatitis
Enrollment Status: Completed
Publish Date: July 11, 2017
Intervention Type: Drug
Study Phase: Phase 4
An Open-Label Study Investigating the Effects of Early Skin Barrier Protection on the Development of Atopic Dermatitis
An Open-Label Study Investigating the Effects of Early Skin Barrier Protection on the Development of Atopic Dermatitis
Enrollment Status: Completed
Publish Date: July 11, 2017
Intervention Type: Drug
Study Phase: Phase 2
View 11 Less Clinical Trials

434 Total Publications

Facial Rash Events in Dupilumab Phase 3 Atopic Dermatitis Trials: A Pooled Analysis.
Facial Rash Events in Dupilumab Phase 3 Atopic Dermatitis Trials: A Pooled Analysis.
Journal: Dermatitis : contact, atopic, occupational, drug
Published: October 30, 2025
View All 434 Publications
Similar Doctors
Experienced in Folliculitis
Dr. Bernard Gasch
Dermatology
Experienced in Folliculitis
Dr. Bernard Gasch
Dermatology

Office

9135 SW Barnes Rd Ste 875, 
Portland, OR 
 (7.2 miles away)
503-297-3440
Languages Spoken:
English
See accepted insurances

Bernard Gasch is a Dermatologist in Portland, Oregon. Dr. Gasch is rated as an Advanced provider by MediFind in the treatment of Folliculitis. His top areas of expertise are Rosacea, Neurocutaneous Melanosis, Giant Congenital Melanocytic Nevus, and Familial Atypical Multiple Mole Melanoma Syndrome.

Experienced in Folliculitis
Dr. Jason Hawkes
Dermatology
Experienced in Folliculitis
Dr. Jason Hawkes
Dermatology

Office

1750 S Harbor Way Ste 330, 
Portland, OR 
 (3.4 miles away)
503-245-1525
Languages Spoken:
English
See accepted insurances

Jason Hawkes is a Dermatologist in Portland, Oregon. Dr. Hawkes is rated as an Advanced provider by MediFind in the treatment of Folliculitis. His top areas of expertise are Psoriasis, Pustules, Plaque Psoriasis, and Generalized Pustular Psoriasis (GPP).

Experienced in Folliculitis
Dr. Russell Young
Dermatology
Experienced in Folliculitis
Dr. Russell Young
Dermatology

Silver Falls Dermatology LLC

1793 13th St SE, 
Salem, OR 
 (45.0 miles away)
866-599-3376
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Russell Young is a Dermatologist in Salem, Oregon. Dr. Young is rated as a Distinguished provider by MediFind in the treatment of Folliculitis. His top areas of expertise are Basal Cell Skin Cancer, Actinic Keratosis, Extramammary Paget Disease, and Squamous Cell Skin Carcinoma.

VIEW MORE FOLLICULITIS DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Simpson's expertise for a condition
ConditionClose
  • Elite
  • Atopic Dermatitis
    Dr. Simpson is
    Elite
    . Learn about Atopic Dermatitis.
    See more Atopic Dermatitis experts
  • Distinguished
  • Plaque Psoriasis
    Dr. Simpson is
    Distinguished
    . Learn about Plaque Psoriasis.
    See more Plaque Psoriasis experts
  • Psoriasis
    Dr. Simpson is
    Distinguished
    . Learn about Psoriasis.
    See more Psoriasis experts
  • Advanced
  • Actinic Keratosis
    Dr. Simpson is
    Advanced
    . Learn about Actinic Keratosis.
    See more Actinic Keratosis experts
  • Basal Cell Skin Cancer
    Dr. Simpson is
    Advanced
    . Learn about Basal Cell Skin Cancer.
    See more Basal Cell Skin Cancer experts
  • Contact Dermatitis
    Dr. Simpson is
    Advanced
    . Learn about Contact Dermatitis.
    See more Contact Dermatitis experts
  • Folliculitis
    Dr. Simpson is
    Advanced
    . Learn about Folliculitis.
    See more Folliculitis experts
  • Melanoma
    Dr. Simpson is
    Advanced
    . Learn about Melanoma.
    See more Melanoma experts
  • Molluscum Contagiosum
    Dr. Simpson is
    Advanced
    . Learn about Molluscum Contagiosum.
    See more Molluscum Contagiosum experts
View All 9 Advanced Conditions
  • Experienced
  • Acne
    Dr. Simpson is
    Experienced
    . Learn about Acne.
    See more Acne experts
  • Acrogeria, Gottron Type
    Dr. Simpson is
    Experienced
    . Learn about Acrogeria, Gottron Type.
    See more Acrogeria, Gottron Type experts
  • Alopecia Areata
    Dr. Simpson is
    Experienced
    . Learn about Alopecia Areata.
    See more Alopecia Areata experts
  • Autosomal Recessive Hypotrichosis
    Dr. Simpson is
    Experienced
    . Learn about Autosomal Recessive Hypotrichosis.
    See more Autosomal Recessive Hypotrichosis experts
  • Bazex Syndrome
    Dr. Simpson is
    Experienced
    . Learn about Bazex Syndrome.
    See more Bazex Syndrome experts
  • Bowen's Disease
    Dr. Simpson is
    Experienced
    . Learn about Bowen's Disease.
    See more Bowen's Disease experts
View All 53 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.